SEARCH

SEARCH BY CITATION

References

  • 1
    Haagsma EB, Hagens VE, Schaapveld M, van den Berg AP, de Vries EG, Klompmaker IJ, et al. Increased cancer risk after liver transplantation: a population-based study. J Hepatol 2001; 34: 8491.
  • 2
    Pruthi J, Medkiff KA, Esrason KT, Donovan JA, Yoshida EM, Erb SR, et al. Analysis of causes of death in liver transplant recipients who survived more than 3 years. Liver Transpl 2001; 7: 811815.
  • 3
    Herrero JI, Lucena JF, Quiroga J, Sangro B, Pardo F, Rotellar F, et al. Liver transplantation recipients older than 60 years have lower survival and higher incidence of malignancy. Am J Transplant 2003; 3: 14071412.
  • 4
    Benlloch S, Berenguer M, Prieto M, Moreno R, San Juan F, Rayon M, et al. De novo internal neoplasms after liver transplantation: increased risk and aggressive behavior in recent years? Am J Transplant 2004; 4: 506604.
  • 5
    Gomez-Manero N, Herrero JI, Quiroga J, Sangro B, Pardo F, Cienfuegos JA, et al. Prognostic model for early acute rejection after liver transplantation. Liver Transpl 2001; 7: 246254.
  • 6
    Registro de Cancer de Navarra, Sección de Enfermedades no Transmisibles y Estadísticas Vitales. Incidence and mortality of cancer in Navarra, 1993-1997. Tendecies in the last 25 years. An Sist Sanit Navar 2001; 24: 339362.
  • 7
    Levy M, Backman L, De Husberg B, Goldstein R, McMillan R, Gibbs J, et al. De novo malignancy following liver transplantation: a single-center study. Transplant Proc 1993; 25: 13971399.
  • 8
    Sheil AGR. Malignancy following liver transplantation: a report from the Australian Combined Liver Transplant Registry. Transplant Proc 1995; 27: 1247.
  • 9
    Jonas S, Rayes N, Neumann U, Neuhaus R, Bechstein WO, Guckelberger O, et al. De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocite globulin. Cancer 1997; 80: 11411150.
  • 10
    Bessa X, Andreu H, Cirera I, Rimola A, Navasa M, Grande L, et al. Tumores de novo en pacientes adultos con trasplante hepático. Gastroenterol Hepatol 1997; 20: 442445.
  • 11
    Berenguer M, Prieto M, Bustamante M, Carrasco D, Lopez-Andujar R, Mir J, et al. Incidencia de neoplasias internas después de trasplante hepático. Med Clin (Barc) 1998; 111: 481484.
  • 12
    Peyregne V, Ducerf C, Adham M, de la Roche E, Bertoux N, Bancel B, et al. De novo cancer after orthotopic liver transplantation. Transplant Proc 1998; 30: 14841485.
  • 13
    Galve ML, Cuervas-Mons V, Figueras J, Herrero I, Mata M, Clemente G, et al. Incidence and outcome of de novo malignancies after liver transplantation. Transplant Proc 1999; 31: 12751277.
  • 14
    Jain A, DiMartini A, Kashyap R, Youk A, Rohal S, Fung J. Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus. Transplantation 2000; 70: 13351342.
  • 15
    Sheiner P, Magliocca JF, Bodian CA, Kim-Schluger L, Alataca G, Guarrera JV, et al. Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation 2000; 69: 781789.
  • 16
    Jaurrieta E, Casais L, Figueras J, Ramos E, Jama C, Rafecas A, et al. Análisis de 500 trasplantes hepáticos en el hospital de Bellvitge. Med Clin (Barc) 2000; 115: 521529.
  • 17
    Bellamy CO, DiMartini AM, Ruppert K, Jain A, Dodson F, Torbenson M, et al. Liver transplantation for alcoholic cirrhosis: long-term follow-up and impact of disease recurrence. Transplantation 2001; 72: 619626.
  • 18
    Xiol X, Guardiola J, Menendez S, Lama C, Figueras J, Marcoval J, et al. Risk factors for development of de novo neoplasia after liver transplantation. Liver Transpl 2001; 7: 971975.
  • 19
    Catena F, Nardo B, Liviano d'Arcangelo G Stefoni S, Arpesella G, Faenza A, et al. De novo malignancies after organ transplantation. Transplant Proc 2001; 33: 18581859.
  • 20
    Jimenez C, Rodríguez D, Marques E, Loinaz C, Alonso O, Hernandez-Vallejo G, et al. De novo tumors after orthotopic liver transplantation. Transplant Proc 2002; 34: 297298.
  • 21
    Sanchez EQ, Marubashi S, Jung G, Levy MF, Goldstein RM, Molmenti EP, et al. De novo tumors after liver transplantation: a single institution experience. Liver Transpl 2002; 8: 285291.
  • 22
    Saigal S, Norris S, Muiesan P, Rela M, Heaton N, O'Grady J. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl 2002; 8: 482487.
  • 23
    Catalina MV, de Diego A, Garcia-Sanchez A, Escudero M, Salcedo M, Banares R, et al. Caracterización de los tumores malignos de novo en el trasplante hepático. Gastroenterol Hepatol 2003; 26: 5763.
  • 24
    Duvoux C, Delacroix I, Richardet JP, Roudot-Thoradal F, Metreau JM, Fagniez PM, et al. Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alholic cirrhosis. Transplantation 1999; 67: 418421.
  • 25
    Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348: 16811691.
  • 26
    Eddy DM. Screening for lung cancer. Ann Intern Med 1989; 111: 232237.
  • 27
    Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuiness G, Miettinen OS, et al. Early lung cancer project: overall design and findings from baseline screening. Lancet 1999; 354: 99105.